Responsive Neurostimulation to Control Partial Epileptic Seizure

submitted by: mcgheek
Jonathan C. Edwards, M.D., Director of MUSC's Comprehensive Epilepsy Center, who participated in the clinical trial that led to recent FDA approval of responsive neurostimulation (RNS) for partial epileptic seizure, discusses how RNS offers for the first time two-way communication with the brain. The RNS device first records seizure activity and, once the electronic signature of a patient's seizures is identified, is programmed to recognize and disrupt that signature.Read “Conversing with...

Treatment of Epilepsy

submitted by: alex01
Michael Rogawski (University of California, Davis) summarizes his research on the antiepileptic activity of neurosteroids (e.g. ganaxolone, allopregnanolone). They are allosteric modulators of GABAA receptors and are active in many models of epilepsy. They are expected, however, to be most effective in catamenial epilepsy, infantile spasms or adult partial seizures. National Institutes of Health (NIH) is currently sponsoring a clinical trial of progesterone (precursor of allopregnanolone)...

Nihal de Lanerolle (Epilepsy Session)

submitted by: hhv-6foundation

"Human temporal lobe epilepsy and HHV-6"
6th International Conference on HHV-6 & 7 in Baltimore, Maryland, USA
Day 3 - June 22, 2008 - Epilepsy Session

Leon Epstein (Epilepsy Session)

submitted by: hhv-6foundation

"Human herpesvirus-6 and 7 infection in febrile status epilepticus"
6th International Conference on HHV-6 & 7 in Baltimore, Maryland, USA
Day 3 - June 22, 2008 - Epilepsy Session

Shlomo Shinnar (Epilepsy Session)

submitted by: hhv-6foundation

"The role of HHV-6B in status epilepticus and epilepsy"
6th International Conference on HHV-6 & 7 in Baltimore, Maryland, USA
Day 3 - June 22, 2008 - Epilepsy Session